/
BIOA
$10.43-$0.05 (-0.48%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$481.0M
46M shares
52-week range
$4.38 – $25.96
28% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Change$-7.88
BioAge Labs, Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.
www.bioagelabs.com- Employees
- 62
- IPO / List date
- Sep 26, 2024
- HQ
- EMERYVILLE, CA
Held by traders on TradeandTell
No one on the platform currently holds BIOA.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 138,588 | $2.4M |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded BIOA yet.
